Making Prostate Cancer Care Affordable in Nigeria: A Closer Look at Doctor's Views

Prostate cancer hits harder in poorer countries. Two drugs, abiraterone and enzalutamide, can help, but they're expensive. Many patients in Nigeria can't afford them. A recent survey asked doctors about this problem and possible solutions. The survey asked 104 doctors in Nigeria about prostate cancer treatment. Most patients in Nigeria are diagnosed late, when the cancer is already advanced. This makes treatment harder and more expensive. Many doctors don't know about studies that show lower doses of these drugs can work just as well. This is a big problem because most patients can't afford the full dose.Money is a huge barrier. Only a small number of patients can afford abiraterone, and even fewer can afford enzalutamide. But there's hope. Many doctors think using lower doses could help more patients. It could make treatment cheaper and easier to stick with. Most doctors are open to trying lower doses of abiraterone. The survey shows a big gap in knowledge about these drugs. If more doctors knew about the studies, they could help more patients. Lower doses might be the key to making treatment affordable for everyone.